Skip to main content

Advertisement

We’re sorry, something doesn't seem to be working properly. Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment

  • Marlies E Heuvers1,
  • Joachim G Aerts1, 2,
  • Robin Cornelissen1,
  • Harry Groen3,
  • Henk C Hoogsteden1 and
  • Joost P Hegmans1Email author
BMC Cancer201212:580

DOI: 10.1186/1471-2407-12-580

Received: 17 August 2012

Accepted: 15 November 2012

Published: 5 December 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
17 Aug 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
9 Sep 2012 Reviewed Reviewer Report - Arnaud Scherpereel
4 Oct 2012 Reviewed Reviewer Report - Stefan Holdenrieder
23 Oct 2012 Author responded Author comments - joost hegmans
Resubmission - Version 3
23 Oct 2012 Submitted Manuscript version 3
Publishing
15 Nov 2012 Editorially accepted
5 Dec 2012 Article published 10.1186/1471-2407-12-580

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pulmonary Medicine, Erasmus Medical Center
(2)
Department of Pulmonary Medicine, Amphia Hospital
(3)
Department of Pulmonary Medicine, University Medical Centrum Groningen

Advertisement